KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

TherapeuticsMD (TXMD) Debt Ratio (2018 - 2022)

TherapeuticsMD filings provide 8 years of Debt Ratio readings, the most recent being 0.7 for Q3 2022.

  • On a quarterly basis, Debt Ratio fell 21.53% to 0.7 in Q3 2022 year-over-year; TTM through Sep 2022 was 0.7, a 21.53% decrease, with the full-year FY2021 number at 1.11, down 15.12% from a year prior.
  • Debt Ratio hit 0.7 in Q3 2022 for TherapeuticsMD, up from 0.62 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 1.52 in Q1 2022 to a low of 0.31 in Q3 2018.
  • Median Debt Ratio over the past 5 years was 0.78 (2019), compared with a mean of 0.83.
  • Biggest five-year swings in Debt Ratio: surged 151.28% in 2019 and later tumbled 33.38% in 2021.
  • TherapeuticsMD's Debt Ratio stood at 0.35 in 2018, then skyrocketed by 111.39% to 0.73 in 2019, then surged by 78.86% to 1.31 in 2020, then fell by 15.12% to 1.11 in 2021, then crashed by 37.08% to 0.7 in 2022.
  • The last three reported values for Debt Ratio were 0.7 (Q3 2022), 0.62 (Q2 2022), and 1.52 (Q1 2022) per Business Quant data.